{"id":2219,"date":"2026-10-12T22:49:24","date_gmt":"2026-10-12T14:49:24","guid":{"rendered":"http:\/\/www.puriactives.com\/en\/?p=2219"},"modified":"2026-10-12T22:49:40","modified_gmt":"2026-10-12T14:49:40","slug":"2219","status":"publish","type":"post","link":"http:\/\/www.puriactives.com\/en\/?p=2219","title":{"rendered":"NanoActive™ 10-HDA"},"content":{"rendered":"

01 \u00b7 NanoActive™ 10-HDA: Nano-Encapsulated Royal Jelly Acid<\/h2>\n

Advanced liposomal active ingredient. Powered by PURISOME\u00ae FlexVes™ flexible-vesicle liposome technology. Royal Jelly, Re-Engineered. PuriPharm Co., Ltd.<\/p>\n

\"\"<\/p>\n

02 \u00b7 The Royal Jelly Signature Molecule<\/h2>\n

Royal jelly contains proteins, sugars, lipids, amino acids, and trace components. 10-HDA is a characteristic fatty acid and a marker in research and quality evaluation. It provides a defined molecular active beyond the traditional natural-ingredient concept.<\/p>\n

Identity: 10-Hydroxy-2-Decenoic Acid; 10-HDA\/10-H2DA; Queen Bee Acid; Royal Jelly Acid; a medium-chain \u03c9-hydroxy unsaturated fatty acid and characteristic royal jelly lipid.<\/p>\n

10-HDA is a multifunctional bioactive lipid. Whole-royal-jelly effects cannot all be attributed to it; this presentation focuses on the lipid\u2019s evidence.<\/p>\n

03 \u00b7 From Royal Jelly to 10-HDA<\/h2>\n

Traditional natural origin, molecular precision, and nano delivery.<\/p>\n

1 Royal jelly, a traditional natural ingredient. 2 Identify the signature bioactive lipid. 3 Define molecular 10-HDA. 4 Study multiple skin biological pathways. 5 NanoActive™ liposomal delivery.<\/p>\n

Applications: premium skin and scalp care. Defined. Studied. Delivered.<\/p>\n

\"\"<\/p>\n

04 \u00b7 10-HDA Molecular Science<\/h2>\n

2D structure source: PubChem CID 5312738.<\/p>\n

Formula C10H18O3; molecular weight approximately 186.25. Structure: \u03b1,\u03b2-unsaturated carboxylic acid, terminal hydroxyl, and a medium-chain fatty acid backbone. Class: medium-chain \u03c9-hydroxy unsaturated fatty acid.<\/p>\n

Potential: lipid interactions with skin lipids; hydroxyl-mediated hydrogen bonding; amphiphilic biofilm interactions; and a structural basis for epidermal biology research.<\/p>\n

\"\"<\/p>\n

05 \u00b7 One Royal Jelly Lipid, Multiple Skin Pathways<\/h2>\n

Seven research directions: barrier support, moisture\/NMF, environmental stress defense, collagen\/photoaging, skin tone, microbiome support, and soothing.<\/p>\n

The presentation organizes an evidence network around one defined bioactive lipid. This mechanism map does not establish finished-product clinical efficacy.<\/p>\n

\"\"<\/p>\n

06 \u00b7 Filaggrin: From 10-HDA to Natural Moisturizing Factors<\/h2>\n

Gu, Zeng, and Maeda (2017) found induction of filaggrin and free amino acids in cultured 3D human epidermis. This extends hydration concepts into cornification and NMF biology.<\/p>\n

Key findings: increased filaggrin expression, FLG mRNA\/protein, stratum-corneum free amino acids, and support for NMF formation.<\/p>\n

Pathway: 10-HDA, increased filaggrin, free amino acids, NMF reserves, and moisture-retention\/barrier appearance concepts.<\/p>\n

Source: Cosmetics. 2017;4(4):48. DOI: 10.3390\/cosmetics4040048. In vitro 3D epidermis.<\/p>\n

\"\"<\/p>\n

07 \u00b7 Barrier Mechanism Map<\/h2>\n

From keratinocytes to the stratum corneum: differentiation support, increased granular-layer filaggrin, amino acid release, NMF reserves, hydration, and a stronger-looking barrier.<\/p>\n

Layer schematic: stratum corneum, NMF\/hydration; stratum granulosum, filaggrin processing and amino acids\/NMF; keratinocytes, differentiation\/cornification and the proposed 10-HDA starting point.<\/p>\n

Source: Gu et al. Cosmetics. 2017;4(4):48. DOI: 10.3390\/cosmetics4040048. The diagram illustrates mechanisms and does not establish product penetration depth.<\/p>\n

\"\"<\/p>\n

08 \u00b7 NQO1: Supporting Epidermal Stress Defense<\/h2>\n

Okumura et al. (2021) identified 10-HDA as an important royal jelly fatty acid inducing NQO1, an antioxidant\/detoxification enzyme.<\/p>\n

Care contexts: UV oxidative stress, ROS accumulation, pollution\/environmental stress, and early oxidative-aging signs. The positioning is defense support, without sunscreen or medicinal claims.<\/p>\n

Pathway: 10-HDA, cellular stress-response signals, increased NQO1, enhanced antioxidant defense, and reduced oxidative-stress burden.<\/p>\n

Source: Int J Mol Sci. 2021;22(23):12973. DOI: 10.3390\/ijms222312973. In vitro cellular\/epidermal models.<\/p>\n

\"\"<\/p>\n

09 \u00b7 10-HDA and UVA-Induced Dermal Damage<\/h2>\n

Human dermal fibroblast pathway: UVA, increased ROS, JNK\/p38 signaling, increased MMP-1\/MMP-3, and collagen breakdown\/photoaging.<\/p>\n

10-HDA findings: lower ROS and senescence-related changes, modulated MMP-1\/MMP-3, supported type I collagen expression, and protection against UVA cellular damage.<\/p>\n

Zheng et al. (2013) connect ROS management with downstream MMP modulation and collagen protection.<\/p>\n

Source: J Eur Acad Dermatol Venereol. 2013;27:1269\u20131277. DOI: 10.1111\/j.1468-3083.2012.04707.x. In vitro human fibroblasts.<\/p>\n

\"\"<\/p>\n

10 \u00b7 Royal Jelly Biology and Collagen Science<\/h2>\n

This section concerns whole royal jelly, separate from purified 10-HDA.<\/p>\n

Park et al. (2011), human skin fibroblast UVB model: royal jelly enhanced collagen production, with TGF-\u03b21-related responses, type I procollagen, and extracellular-matrix support.<\/p>\n

Concept: protect and preserve youthful-looking skin. Whole royal jelly and 10-HDA findings inform complementary collagen narratives, but whole-royal-jelly results cannot be fully attributed to 10-HDA. The source schematic includes Royal Jelly\/10-HDA; the experiment itself tested whole royal jelly.<\/p>\n

Source: J Med Food. 2011;14(9):899\u2013906. DOI: 10.1089\/jmf.2010.1363. In vitro.<\/p>\n

\"\"<\/p>\n

11 \u00b7 10-HDA and Melanogenesis<\/h2>\n

Peng et al. (2017) studied B16F1 melanoma cells and topical mouse skin, showing melanogenesis inhibition involving MITF, Tyrosinase, and TRP pathways.<\/p>\n

Models assessed melanin\/tyrosinase and topical tone-related indicators. Multi-target concepts support clearer-looking tone and appearance; no pigment-disease treatment claims.<\/p>\n

Pathway: 10-HDA inhibition, MITF modulation, Tyrosinase, TRP-1\/TRP-2, and melanin synthesis.<\/p>\n

Source: BMC Complement Altern Med. 2017;17:392. DOI: 10.1186\/s12906-017-1888-8.<\/p>\n

\"\"<\/p>\n

12 \u00b7 Staphylococcus aureus Biofilm Research<\/h2>\n

In vitro findings: reduced biofilm formation, EPS production, adhesion, aggregation, and mature-biofilm viability.<\/p>\n

Genes: reduced sarA, agrA, and hla, associated with biofilm regulation, quorum signaling, and \u03b1-hemolysin virulence.<\/p>\n

Positioning: a microbiome-friendly skin-purifying strategy managing unfavorable biofilms and environments. Care concepts include oily\/blemish-prone skin, sensitive-skin microbiome care, scalp care, skin cleansing care, and fragile barriers. These findings do not establish selective support for all beneficial species.<\/p>\n

Gao et al. Molecules. 2022;27(5):1485. DOI: 10.3390\/molecules27051485.<\/p>\n

13 \u00b7 The Delivery Challenge<\/h2>\n

01 Poor aqueous solubility limits direct water-based use. 02 Limited oil solubility constrains conventional oil delivery. 03 Free-state penetration depends on dosage-form design. 04 Direct addition can be difficult to disperse and restrict formulation options.<\/p>\n

Biological activity does not by itself establish bioavailability at the intended interface.<\/p>\n

14 \u00b7 PURISOME\u00ae FlexVes™: Why Liposomes<\/h2>\n

A lipid-bilayer vesicle is a membrane-related carrier architecture for loading\/dispersing 10-HDA. It aims to improve aqueous dispersion, compatibility with stratum-corneum lipids, and delivery\/deposition potential.<\/p>\n

Values: nanoscale delivery, lipid compatibility, dispersion, skin-deposition potential, controlled skin interactions, and formulation flexibility.<\/p>\n

The vesicle image is a mechanism schematic, not measured particle-size or encapsulation-efficiency data.<\/p>\n

\"\"<\/p>\n

15 \u00b7 2026 Independent Nano-Delivery Evidence<\/h2>\n

Gao et al. (2026) studied Hyalurosomes encapsulating a 10-HDA\/matrine deep eutectic solvent, using ex vivo skin and cellular models.<\/p>\n

Formulation\/delivery: improved dissolution\/dispersion and stability, with increased deposition in stratum corneum, viable epidermis, and dermis.<\/p>\n

Cells: reduced HaCaT ROS, IL-1\u03b1\/IL-6\/TNF-\u03b1; increased HaCaT migration; reduced HFF-1 senescence phenotype.<\/p>\n

The formulation is distinct from NanoActive™ 10-HDA. It supports the delivery strategy and does not constitute direct product evidence.<\/p>\n

Int J Pharm. 2026;701:127150. DOI: 10.1016\/j.ijpharm.2026.127150.<\/p>\n

16 \u00b7 Free and Nano-Encapsulated 10-HDA<\/h2>\n

Free 10-HDA: limited solubility, dispersion, penetration, and formulation choices.<\/p>\n

NanoActive™ 10-HDA with PURISOME\u00ae FlexVes™: liposomal dispersion, a skin-compatible lipid carrier, improved delivery potential, greater formulation versatility, and modern skin-care design.<\/p>\n

Better delivery offers greater opportunity for biological activity; product performance still requires direct testing.<\/p>\n

17 \u00b7 Integrated Mechanism Network<\/h2>\n

Epidermis: filaggrin, amino acids\/NMF, moisture\/barrier. Dermis: lower ROS\/MMP-1\/MMP-3, collagen preservation. Stress defense: NQO1 and oxidative-defense support. Pigmentation: MITF\/Tyrosinase\/TRP and even-looking tone. Microbiome: biofilm\/virulence modulation and skin-environment concepts.<\/p>\n

One bioactive lipid, multiple pathways. The network combines Gu 2017, Okumura 2021, Zheng 2013, Peng 2017, and Gao 2022, retaining their original model-level attribution.<\/p>\n

\"\"<\/p>\n

18 \u00b7 Five Core Skincare Values<\/h2>\n

01 Barrier recovery: filaggrin\/NMF and hydration foundations. 02 Anti-stress defense: NQO1-related epidermal defenses. 03 Photoaging care: ROS\/MMP and collagen protection. 04 Tone: MITF\/Tyrosinase-related pathways for dull\/uneven appearance. 05 Microbiome: unfavorable-biofilm management and skin-environment support.<\/p>\n

Barrier \u00d7 Defense \u00d7 Collagen \u00d7 Tone \u00d7 Microbiome connects mechanisms to formulation concepts.<\/p>\n

19 \u00b7 Scalp Is Skin<\/h2>\n

Scalp pressures: fragile barrier\/moisture loss, oxidative stress, microbial imbalance, inflammatory environments, and sebum\/pollution.<\/p>\n

Skin mechanisms inform scalp concepts: Filaggrin\/NMF for hydration; NQO1 for stress defense; biofilm management for microbial care; soothing pathways for comfort. These concepts require scalp-specific validation.<\/p>\n

Healthy scalp, a better environment for beautiful hair. The positioning does not claim direct hair growth.<\/p>\n

20 \u00b7 Royal Jelly and Scalp Research Clues<\/h2>\n

A 2024 clinical observation of a medicated hair tonic containing royal jelly extract associated the combination product with improved scalp moisture\/condition and hair condition. Dermal papilla experiments reported changes in some growth-related genes.<\/p>\n

Other actives were present; results cannot all be attributed to royal jelly extract or 10-HDA.<\/p>\n

NanoActive™ positioning: scalp barrier, moisture, soothing, antioxidant defense, and microbiome care. Skin health guides scalp ecological concepts.<\/p>\n

J Soc Cosmet Chem Jpn. 2024;58(1):55\u201364. DOI: 10.5107\/sccj.58.55. Combination-product clinical observation and cell experiments.<\/p>\n

21 \u00b7 Skincare Applications<\/h2>\n

Anti-aging serum, repair serum, barrier cream, sensitive-skin serum, overnight recovery, tone-care serum, blemish-prone care, microbiome products, urban-defense serum, eye-contour care, premium royal jelly concepts, and post-treatment-inspired care.<\/p>\n

Royal Jelly Renewal Serum: photoaging\/collagen concept. Barrier Defense Cream: Filaggrin\u2013NMF hydration concept. Bio-Balance Repair Essence: biofilm-management concept.<\/p>\n

22 \u00b7 Scalp and Hair Applications<\/h2>\n

Scalp serum, ampoule, shampoo, soothing mist, dry-scalp lotion, oily-scalp essence, post-color\/perming scalp care, anti-pollution serum, and premium aging scalp care.<\/p>\n

Royal Scalp Defense Serum: antioxidant\/environmental defense. Scalp Barrier Booster: daily barrier\/hydration care. Nano Royal Jelly Scalp Essence: premium nano-delivery and microbiome concepts.<\/p>\n

23 \u00b7 Value for Formulators<\/h2>\n

01 Easier incorporation addresses free-active solubility, dispersion, and penetration challenges. 02 Lipid-compatible delivery. 03 Water-based formulation design for serums\/lotions. 04 Multiple barrier, antioxidant, aging, tone, and microbiome concepts. 05 Premium storytelling: Royal Jelly \u00d7 Molecular Science \u00d7 Nano Delivery.<\/p>\n

Nature \u00d7 Molecule \u00d7 Nanotechnology combines natural-origin narrative, molecular evidence, and delivery design.<\/p>\n

24 \u00b7 Royal Jelly, Re-Engineered<\/h2>\n

01 A signature royal jelly lipid. 02 Filaggrin\/NMF hydration. 03 Epidermal defense and collagen-protection research. 04 Microbiome\/tone concepts. 05 Advanced liposomal design to address practical delivery barriers.<\/p>\n

NanoActive™ 10-HDA, powered by PURISOME\u00ae FlexVes™.<\/p>\n

25 \u00b7 Positioning Matrix<\/h2>\n

Traditional royal jelly: a strong natural narrative with complex composition. Free 10-HDA: a defined molecule with formulation\/delivery challenges. NanoActive™ 10-HDA: Defined Bioactive + Nano Delivery; Molecular Precision + Advanced Delivery.<\/p>\n

Horizontal axis: evolution of active form. Vertical axis: narrative\/scientific level. The schematic positions the product at molecular precision and advanced delivery; it is a qualitative positioning map, not quantitative comparative data.<\/p>\n

\"\"<\/p>\n

26 \u00b7 References<\/h2>\n

All ten references from the presentation are retained below.<\/p>\n

Molecular-structure source: PubChem CID 5312738. The science concerns 10-HDA (10-Hydroxy-2-Decenoic Acid, C10H18O3), distinct from 10-Hydroxydecanoic Acid (10-HDAA). Final INCI follows the formal PuriPharm Co., Ltd. TDS\/SPEC.<\/p>\n

PuriPharm Co., Ltd. Royal Jelly, Re-Engineered.<\/p>\n

1. Gu L, Zeng H, Maeda K. 10-Hydroxy-2-Decenoic Acid in Royal Jelly Extract Induced Both Filaggrin and Amino Acid in a Cultured Human Three-Dimensional Epidermis Model. Cosmetics. 2017;4(4):48. DOI: 10.3390\/cosmetics4040048.<\/p>\n

2. Zheng J, Lai W, Zhu G, et al. 10-Hydroxy-2-Decenoic Acid Prevents Ultraviolet A-Induced Damage and Matrix Metalloproteinases Expression in Human Dermal Fibroblasts. J Eur Acad Dermatol Venereol. 2013;27:1269\u20131277. DOI: 10.1111\/j.1468-3083.2012.04707.x.<\/p>\n

3. Park HM, Hwang E, Lee KG, et al. Royal Jelly Protects Against Ultraviolet B-Induced Photoaging in Human Skin Fibroblasts via Enhancing Collagen Production. J Med Food. 2011;14(9):899\u2013906. DOI: 10.1089\/jmf.2010.1363.<\/p>\n

4. Peng CC, Sun HT, Lin IP, et al. The Functional Property of Royal Jelly 10-Hydroxy-2-Decenoic Acid as a Melanogenesis Inhibitor. BMC Complement Altern Med. 2017;17:392. DOI: 10.1186\/s12906-017-1888-8.<\/p>\n

5. Okumura N, Ito T, Degawa T, et al. Royal Jelly Protects against Epidermal Stress through Upregulation of the NQO1 Expression. Int J Mol Sci. 2021;22(23):12973. DOI: 10.3390\/ijms222312973.<\/p>\n

6. Gao K, Su B, Dai J, et al. Anti-Biofilm and Anti-Hemolysis Activities of 10-Hydroxy-2-Decenoic Acid against Staphylococcus aureus. Molecules. 2022;27(5):1485. DOI: 10.3390\/molecules27051485.<\/p>\n

7. Perminaite K, Fadda AM, Sinico C, Ramanauskiene K. Formulation of Liposomes Containing Royal Jelly and Their Quality Assessment. DOI: 10.1166\/jnn.2021.19053.<\/p>\n

8. Gao C, Liu F, Yang S, Wang Q, Yang C, Liang R. 10-Hydroxy-2-Decenoic Acid\/Matrine Deep Eutectic Solvent Encapsulated in Hyalurosomes for Enhanced Transdermal Delivery and Antioxidant Efficacy. Int J Pharm. 2026;701:127150. DOI: 10.1016\/j.ijpharm.2026.127150.<\/p>\n

9. Enhanced Skin Penetration of 10-Hydroxy-2-Decenoic Acid via Anionic Polymer Formulations and Skin Hydration Modulation. J Dermatologic Sci Cosmet Technol. 2026;3(1):100144. DOI: 10.1016\/j.jdsct.2025.100144.<\/p>\n

10. The Effectiveness of Medicated Hair Tonic Containing Royal Jelly Extract. J Soc Cosmet Chem Jpn. 2024;58(1):55\u201364. DOI: 10.5107\/sccj.58.55.<\/p>\n","protected":false},"excerpt":{"rendered":"

01 \u00b7 NanoActive™ 10-HDA: Nano-Encapsulated Royal […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[25],"tags":[],"_links":{"self":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2219"}],"collection":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2219"}],"version-history":[{"count":2,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2219\/revisions"}],"predecessor-version":[{"id":2249,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2219\/revisions\/2249"}],"wp:attachment":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2219"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}